Indivior Pharmaceuticals, Inc. INDV Payments to Acquire Held-to-Maturity Securities
Payments to Acquire Held-to-Maturity Securities at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireHeldToMaturitySecurities.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's payments to acquire held-to-maturity securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's payments to acquire held-to-maturity securities?
- Indivior Pharmaceuticals, Inc. (INDV) reported payments to acquire held-to-maturity securities of $5M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's payments to acquire held-to-maturity securities changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's payments to acquire held-to-maturity securities decreased by 0.0% year-over-year, from $5M to $5M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's payments to acquire held-to-maturity securities?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's payments to acquire held-to-maturity securities has grown at a -56.6% compound annual growth rate (CAGR), from $245M to $20M.